DETROIT — Through statewide partnerships with physicians, public health advocates and officials, Blue Cross has seen comprehensive results in addressing the opioid epidemic.
Between 2013 and 2017, Blue Cross Blue Shield of Michigan (BCBSM) saw a 34 percent decrease in opioid prescriptions per 1,000 members, higher than the national average of 29 percent, according to a recently published report.
In a press release, Blue Cross Blue Shield of Michigan President and CEO Daniel J. Loepp said, “Blue Cross Blue Shield of Michigan has been strategic in how we approach the serious opioid epidemic impacting our state, our members and their families. It will take collaborative efforts to combat this very serious health issue and we’re eager to continue enhancing awareness and expanding access to resources and treatment for individuals and families across the state.”
Nationally, BCBSA’s report showed the largest decrease in overall number of opioid prescriptions over the past two years. Additionally, the number of BCBS members who filled at least one opioid prescription is down by 25 percent since 2013.